Moosa Mohammadi
Affiliations: | New York University, New York, NY, United States |
Area:
BiochemistryGoogle:
"Moosa Mohammadi"Mean distance: (not calculated yet)
Children
Sign in to add trainee| Omar A. Ibrahimi | grad student | 2004 | NYU |
| Shaun K. Olsen | grad student | 2006 | NYU |
| Juliya Kalinina | grad student | 2009 | NYU |
| Andrew Beenken | grad student | 2011 | NYU |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chen L, Fu L, Sun J, et al. (2023) Structural basis for FGF hormone signalling. Nature |
| Besch A, Marsiglia WM, Mohammadi M, et al. (2023) Gatekeeper mutations activate FGF receptor tyrosine kinases by destabilizing the autoinhibited state. Proceedings of the National Academy of Sciences of the United States of America. 120: e2213090120 |
| Ying L, Wang L, Guo K, et al. (2021) Paracrine FGFs target skeletal muscle to exert potent anti-hyperglycemic effects. Nature Communications. 12: 7256 |
| Niu J, Zhao J, Wu J, et al. (2020) Curtailing FGF19's mitogenicity by suppressing its receptor dimerization ability. Proceedings of the National Academy of Sciences of the United States of America |
| Xie Y, Zinkle A, Chen L, et al. (2020) Fibroblast growth factor signalling in osteoarthritis and cartilage repair. Nature Reviews. Rheumatology |
| Agoro R, Park MY, Le Henaff C, et al. (2020) C-FGF23 peptide alleviates hypoferremia during acute inflammation. Haematologica |
| Shamsi F, Xue R, Huang TL, et al. (2020) FGF6 and FGF9 regulate UCP1 expression independent of brown adipogenesis. Nature Communications. 11: 1421 |
| Chen L, Marsiglia WM, Chen H, et al. (2020) Molecular basis for receptor tyrosine kinase A-loop tyrosine transphosphorylation. Nature Chemical Biology |
| Besch A, Marsiglia W, Mohammadi M, et al. (2020) Elucidating the Activating Mechanism of Gatekeeper Mutations on Receptor Tyrosine Kinases Biophysical Journal. 118: 53a |
| Zhao L, Niu J, Lin H, et al. (2019) Paracrine-endocrine FGF chimeras as potent therapeutics for metabolic diseases. Ebiomedicine |